skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

TrialScope Atlas

TrialScope Atlas

19 May 2022

TrialScope Atlas

Clinical trial disclosure is a complex process driven by a constantly evolving collection of registry rules and health authority regulations.

Topic Regulation

Citeline Connect, Trialtrove

Clinical Trials Day

17 May 2022

Clinical Trials Day

Topic Clinical Trials

Citeline, Pharmaprojects

Navigate the landscape in our Pharma R&D Annual Review 2022

By Ian Lloyd 14 Apr 2022

Navigate the landscape in our Pharma R&D Annual Review 2022

Our world was disrupted at warp speed during 2020. Are you ready to gain a deeper understanding of the year that changed our perceptions of possible? 

Topic Clinical Trials Diseases Drug Review

TrialScope Disclose

Clinical Trial Transparency Policy

07 Feb 2022

Clinical Trial Transparency Policy

Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.

Topic Policy & Regulation

Citeline

Rare Disease Trial Strategies

02 Feb 2022

Rare Disease Trial Strategies

In our rare disease trial strategies whitepaper, see which sponsors lead the way, understand the geographical location of trials, and delve into the types of therapeutic area, plus much more.

Topic Rare Diseases

TrialScope Disclose

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

11 Jan 2022

Téléchargez votre livre blanc gratuit, « Compte à rebours du nouveau règlement européen sur les essais cliniques : à quoi s'attendre et comment se préparer »

Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.

Topic Business Strategies Clinical Trials

Citeline Connect

Connect the dots between patients and clinical trials

06 Dec 2021

Connect the dots between patients and clinical trials

Accelerate study startup, drive engagement, and enable community and communication surrounding your clinical trials with Citeline Connect, the only end-to-end platform supporting all aspects of clinical trial recruitment.

Topic Business Strategies Clinical Trials

TrialScope Disclose

CTIS Best Practices Whitepaper

19 Oct 2021

CTIS Best Practices Whitepaper

Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.

Topic Clinical Trials

Trialtrove

China trials landscape

18 Oct 2021

Annie Video

本白皮书由Annie Siu博士(PhD,MBA,亚太地区Informa Pharma Intelligence内容总监)与Andrew Benson(MSc,Trialtrove高级总监)撰写,深入剖析中国临床试验的整体格局,介绍临床研究取得的惊人发展。

Topic China

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: